SCHEMBL10684438

SCHEMBL10684438

Cc1cccc(C)c1NC(=O)CN1CCN(CC(O)CC(c2ccc(F)cc2)c2ccc(F)cc2)C(C(N)=O)C1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.58
CYP2D6 P10635 3/20 0.58
MEN1 O00255 3/20 0.58
KMT2A Q03164 3/20 0.58
SLC29A1 Q99808 2/20 0.58
ADRB1 P08588 2/20 0.58
ADRA2A P08913 2/20 0.58
ADRA2B P18089 2/20 0.58
ADRA2C P18825 2/20 0.58
ADRA1A P35348 2/20 0.58
DRD3 P35462 2/20 0.58
HTR2B P41595 2/20 0.58
KCNH2 Q12809 2/20 0.58
LMNA P02545 2/20 0.58
MLNR O43193 1/20 0.58
NR1I2 O75469 1/20 0.58
USP2 O75604 1/20 0.58
CYP1A2 P05177 1/20 0.58
PGR P06401 1/20 0.58
ADORA3 P0DMS8 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10680817 0.88 CYP3A4 (0.67) CYP3A4CYP2D6MEN1KMT2ASLC29A1
SCHEMBL10676648 0.86 ADRA1A (0.73) CYP3A4CYP2D6MEN1KMT2ASLC29A1
Cadaverine Tartrate SCHEMBL10675929 0.84 ADRA1A (0.68) CYP3A4CYP2D6MEN1KMT2ASLC29A1
Cadaverine Tartrate SCHEMBL10799297 0.84 ADRA1A (0.68) CYP3A4CYP2D6MEN1KMT2ASLC29A1
SCHEMBL10795286 0.84 KMT2A (0.57) CYP3A4CYP2D6MEN1KMT2ASLC29A1
SCHEMBL8552549 0.80 ALDH1A1 (0.49) CYP3A4CYP2D6MEN1KMT2ASLC29A1
SCHEMBL10683725 0.79 ADRA1A (0.76) CYP3A4CYP2D6MEN1KMT2ASLC29A1
SCHEMBL10684374 0.79 HTR2A (0.64) CYP3A4CYP2D6MEN1KMT2ASLC29A1
SCHEMBL10682648 0.78 LMNA (0.49) CYP3A4CYP2D6MEN1KMT2ASLC29A1
SCHEMBL10683605 0.78 SLC29A1 (0.68) CYP3A4CYP2D6MEN1KMT2ASLC29A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0068544-B1 NOVEL N-ARYL-PIPERAZINEALKANAMIDES JANSSEN PHARMACEUTICA N.V. (BE) 1987-06-03 EP claimed
US-4766125-A N-aryl-piperazinealkanamides useful for protecting hearts from myocardial injury caused by ischaemia, anoxia or hypoxia JANSSEN PHARMACEUTICA N.V. (BE) 1988-08-23 US disclosed